Tilray Extraction EU
About Tilray Extraction EU
Tilray's European extraction facility in Portugal produces EU-GMP certified cannabis extracts and oils for distribution across European medical cannabis markets.
Key Facts
- 1Operates an EU-GMP certified cannabis cultivation and extraction facility in Cantanhede, Portugal
- 2Supplies medical cannabis extracts to pharmacies across Germany, Italy, and other European markets
Latest News
Tilray's Diversification Strategy Reshapes Cannabis Investment Thesis
TLRY's expansion beyond cannabis into alcohol and wellness creates new valuation framework as traditional sin stock categorization becomes outdated.
Tilray Enters European Cannabis Policy Talks as Regulatory Shift Looms
TLRY participates in EU regulatory discussions as European cannabis markets prepare for potential liberalization across multiple jurisdictions.
Canadian Cannabis Giants Show Mixed Signals Amid Market Consolidation
TLRY, CGC, and VFF navigate regulatory headwinds and operational challenges as the sector searches for sustainable growth paths in 2024.
Frequently Asked Questions
Why did Tilray choose Portugal for European extraction?
Portugal offers favorable climate for cannabis cultivation, competitive operating costs, and EU membership enabling export of GMP-certified products across European medical markets.
What EU markets does Tilray supply?
Tilray's Portuguese facility supplies medical cannabis extracts primarily to Germany, the largest European medical cannabis market, as well as Italy, Poland, and other EU countries.
More Cannabis Companies in Cantanhede
Cannabis Laws
Products
- EU-GMP Cannabis Oils
- Medical Cannabis Extracts
- Standardized Cannabinoid Products
Specialties
Company Details
- Type
- Extraction
- Location
- Cantanhede, Portugal
- Founded
- 2017
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY